Atlas Trials

AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

Clinical trial NCT03182686 · COMPLETED

Trial details

NCT number
NCT03182686
Sponsor
Ampio Pharmaceuticals. Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoarthritis, KneeKnee OsteoarthritisKnee ArthritisKnee Pain Chronic
Start date
2017-06-19
Primary completion
2017-12-07
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.